- Home
- ACTU vs CURR Comparison
ACTU vs CURR Comparison
Compare ACTU & CURR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACTU
- CURR
- Stock Information
- Founded
- ACTU 2015
- CURR 2013
- Country
- ACTU United States
- CURR Singapore
- Employees
- ACTU N/A
- CURR N/A
- Industry
- ACTU
- CURR Business Services
- Sector
- ACTU
- CURR Consumer Discretionary
- Exchange
- ACTU NYSE
- CURR Nasdaq
- Market Cap
- ACTU 154.3M
- CURR 73.0M
- IPO Year
- ACTU 2024
- CURR N/A
- Fundamental
- Price
- ACTU $6.70
- CURR $1.57
- Analyst Decision
- ACTU Strong Buy
- CURR Strong Buy
- Analyst Count
- ACTU 1
- CURR 1
- Target Price
- ACTU $20.00
- CURR $3.50
- AVG Volume (30 Days)
- ACTU 35.6K
- CURR 580.0K
- Earning Date
- ACTU 05-21-2025
- CURR 05-11-2025
- Dividend Yield
- ACTU N/A
- CURR N/A
- EPS Growth
- ACTU N/A
- CURR N/A
- EPS
- ACTU N/A
- CURR N/A
- Revenue
- ACTU N/A
- CURR $48,723,898.00
- Revenue This Year
- ACTU N/A
- CURR N/A
- Revenue Next Year
- ACTU N/A
- CURR N/A
- P/E Ratio
- ACTU N/A
- CURR N/A
- Revenue Growth
- ACTU N/A
- CURR N/A
- 52 Week Low
- ACTU $5.51
- CURR $1.19
- 52 Week High
- ACTU $11.73
- CURR $7.08
- Technical
- Relative Strength Index (RSI)
- ACTU N/A
- CURR N/A
- Support Level
- ACTU N/A
- CURR N/A
- Resistance Level
- ACTU N/A
- CURR N/A
- Average True Range (ATR)
- ACTU 0.00
- CURR 0.00
- MACD
- ACTU 0.00
- CURR 0.00
- Stochastic Oscillator
- ACTU 0.00
- CURR 0.00
About ACTU ACTUATE THERAPEUTICS INC
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.
About CURR Currenc Group Inc. Ordinary Shares
Currenc Group Inc is a fintech banking platform for e-wallets, financial institutions and merchants world-wide, delivering frictionless interoperable real-time fund transfers and instant messaging.